Zulian Francesco, Woo Patricia, Athreya Balu H, Laxer Ronald M, Medsger Thomas A, Lehman Thomas J A, Cerinic Marco Matucci, Martini Giorgia, Ravelli Angelo, Russo Ricardo, Cuttica Ruben, de Oliveira Sheila Knupp Feitosa, Denton Christopher P, Cozzi Franco, Foeldvari Ivan, Ruperto Nicolino
Dipartimento di Pediatria, University of Padua, Padua, Italy.
Arthritis Rheum. 2007 Mar 15;57(2):203-12. doi: 10.1002/art.22551.
To develop criteria for the classification of systemic sclerosis (SSc) in children (juvenile SSc).
The study consisted of 3 phases: 1) collection of data on the signs and symptoms of actual patients with juvenile SSc that are useful for defining involvement of a particular organ; 2) selection of the parameters essential for the classification of juvenile SSc and preparation of a set of provisional classification criteria (PCC) using 2 Delphi surveys; 3) consensus conference consisting of 2 steps: discussion and rating of clinical profiles of 160 patients with definite juvenile SSc, possible juvenile SSc, or other fibrosing diseases as "having or not having juvenile SSc," using nominal group technique, and defining those PCC with the best statistical performance and highest face validity by using the clinical profiles of patients with definite juvenile SSc as the gold standard.
In phase 1, 55 centers submitted clinical data on 153 patients with juvenile SSc. A total of 48 signs and symptoms were derived from these patient data and were used to define 9 organ system categories (cutaneous, vascular, gastrointestinal, respiratory, renal, cardiac, neurologic, musculoskeletal, and serologic). During phase 2, these were reduced to 21 criteria (3 major criteria [Raynaud's phenomenon, proximal skin sclerosis/induration of the skin, and sclerodactyly] and 18 minor criteria) and combined to generate 86 different PCC. At the consensus conference, these 86 definitions were tested on the case profiles of 127 patients with juvenile SSc. The PCC with the highest ranking were proximal sclerosis/induration and at least 2 minor criteria.
These provisional classification criteria for juvenile SSc will help standardize the conduct of clinical research, epidemiologic and outcome studies, and therapeutic trials.
制定儿童系统性硬化症(juvenile SSc)的分类标准。
该研究包括3个阶段:1)收集有关儿童系统性硬化症实际患者的体征和症状数据,这些数据有助于确定特定器官的受累情况;2)选择儿童系统性硬化症分类所需的参数,并通过2轮德尔菲调查制定一套临时分类标准(PCC);3)共识会议包括2个步骤:使用名义群体技术,对160例明确的儿童系统性硬化症、可能的儿童系统性硬化症或其他纤维化疾病患者的临床资料进行讨论并评定为“患有或不患有儿童系统性硬化症”,并以明确的儿童系统性硬化症患者的临床资料作为金标准,确定统计性能最佳且表面效度最高的PCC。
在第1阶段,55个中心提交了153例儿童系统性硬化症患者的临床数据。从这些患者数据中得出了总共48种体征和症状,并用于定义9个器官系统类别(皮肤、血管、胃肠道、呼吸、肾脏、心脏、神经、肌肉骨骼和血清学)。在第2阶段,这些标准减少到21条(3条主要标准[雷诺现象、近端皮肤硬化/皮肤硬结和指端硬化]和18条次要标准),并组合生成86种不同的PCC。在共识会议上,对127例儿童系统性硬化症患者的病例资料测试了这86种定义。排名最高的PCC是近端硬化/硬结和至少2条次要标准。
这些儿童系统性硬化症的临时分类标准将有助于规范临床研究、流行病学和结局研究以及治疗试验的开展。